+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

LAMEA Meningococcal Vaccine Market By Brand, By Type, By Age Group, By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5241467
  • Report
  • January 2021
  • Region: Middle East, Africa
  • 78 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Bio-Med Pvt. Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • MORE
The Latin America, Middle East and Africa Meningococcal Vaccine Market is expected to witness market growth of 9.5% CAGR during the forecast period (2020-2026).

The access to meningococcal vaccines is increasing in developing countries including Africa. This is mainly due to the increasing support of global organizations assisting vaccine procurement, prequalification, and funding is strengthening the lucrativeness of the market. Manufacturers are aiming at these under-penetrated markets to propel their growth in the meningococcal market.

Manufacturers are focused to incorporate advanced technologies in the manufacturing processes in order to develop new and more effective vaccines. For example, GlaxoSmithKline Plc. used new formulations, like a fully liquid production of a tetravalent vaccine for MenACWY and Menveo. Researchers nowadays are focused on the development of a single vaccine capable of tackling all five serogroups, A, B, C, W, and Y of meningococcus and it is the key area of focus for many vaccine manufacturing companies.

The meningococcal vaccine market is likely to experience substantial market growth in the coming years owing to surge in the adoption of immunization programs in several countries across the globe. In addition to it, the outbreak of meningococcal in several countries has resulted in increased demand for meningococcal vaccines, this, in turn, improves the growth of the market. However, in most of the countries, stringent regulations have been imposed for the approval of novel vaccines and it is expected to hinder the market growth. In contrast to this, increasing R&D for meningococcal vaccines and an increase in healthcare spending across the globe provide significant growth in lucrative opportunities for the market players of the meningococcal vaccine.

Based on Brand, the market is segmented into Bexsero, Trumenba, Nimenrix, Menactra, Menveo and Other Brands. Based on Type, the market is segmented into Bivalent, Quadrivalent and Other Types. Based on Age Group, the market is segmented into Infants (0 to 2 years) and Children (2 years & above). Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GlaxoSmithKline PLC (GSK), Pfizer, Inc., Sanofi S.A., Walvax Biotechnology Co., Ltd., Bio-Manguinhos (Oswaldo Cruz Foundation), Bio-Med Pvt. Ltd., Chongqing Zhifei Biological Products Co., Ltd., Hualan Biological Engineering, Inc., Incepta Pharmaceuticals Ltd. and Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)

Scope of the Study

Market Segments covered in the Report:

By Brand
  • Bexsero
  • Trumenba
  • Nimenrix
  • Menactra
  • Menveo
  • Other Brands
By Type
  • Bivalent
  • Quadrivalent
  • Other Types
By Age Group
  • Infants (0 to 2 years)
  • Children (2 years & above)
By Country
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA
Companies Profiled
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Bio-Med Pvt. Ltd.
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Meningococcal Vaccine Market, by Brand
1.4.2 LAMEA Meningococcal Vaccine Market, by Type
1.4.3 LAMEA Meningococcal Vaccine Market, by Age Group
1.4.4 LAMEA Meningococcal Vaccine Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Recent Developments in Meningococcal Vaccine Market

Chapter 4. LAMEA Meningococcal Vaccine Market by Brand
4.1 LAMEA Bexsero Market by Country
4.2 LAMEA Trumenba Market by Country
4.3 LAMEA Nimenrix Market by Country
4.4 LAMEA Menactra Market by Country
4.5 LAMEA Menveo Market by Country
4.5.1.1 LAMEA Other Brands Market by Country

Chapter 5. LAMEA Meningococcal Vaccine Market by Type
5.1 LAMEA Bivalent Market by Country
5.2 LAMEA Quadrivalent Market by Country
5.3 LAMEA Other Types Market by Country

Chapter 6. LAMEA Meningococcal Vaccine Market by Age Group
6.1 LAMEA Children (2 years & above) and Adults Market by Country
6.2 LAMEA Infants(0 to 2 years) Market by Country

Chapter 7. LAMEA Meningococcal Vaccine Market by Country
7.1 Brazil Meningococcal Vaccine Market
7.1.1 Brazil Meningococcal Vaccine Market by Brand
7.1.2 Brazil Meningococcal Vaccine Market by Type
7.1.3 Brazil Meningococcal Vaccine Market by Age Group
7.2 Argentina Meningococcal Vaccine Market
7.2.1 Argentina Meningococcal Vaccine Market by Brand
7.2.2 Argentina Meningococcal Vaccine Market by Type
7.2.3 Argentina Meningococcal Vaccine Market by Age Group
7.3 UAE Meningococcal Vaccine Market
7.3.1 UAE Meningococcal Vaccine Market by Brand
7.3.2 UAE Meningococcal Vaccine Market by Type
7.3.3 UAE Meningococcal Vaccine Market by Age Group
7.4 Saudi Arabia Meningococcal Vaccine Market
7.4.1 Saudi Arabia Meningococcal Vaccine Market by Brand
7.4.2 Saudi Arabia Meningococcal Vaccine Market by Type
7.4.3 Saudi Arabia Meningococcal Vaccine Market by Age Group
7.5 South Africa Meningococcal Vaccine Market
7.5.1 South Africa Meningococcal Vaccine Market by Brand
7.5.2 South Africa Meningococcal Vaccine Market by Type
7.5.3 South Africa Meningococcal Vaccine Market by Age Group
7.6 Nigeria Meningococcal Vaccine Market
7.6.1 Nigeria Meningococcal Vaccine Market by Brand
7.6.2 Nigeria Meningococcal Vaccine Market by Type
7.6.3 Nigeria Meningococcal Vaccine Market by Age Group
7.7 Rest of LAMEA Meningococcal Vaccine Market
7.7.1 Rest of LAMEA Meningococcal Vaccine Market by Brand
7.7.2 Rest of LAMEA Meningococcal Vaccine Market by Type
7.7.3 Rest of LAMEA Meningococcal Vaccine Market by Age Group

Chapter 8. Company Profiles
8.1 GlaxoSmithKline PLC (GSK)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals:
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.1 Financial Analysis
8.2.2 Segmental and Regional Analysis
8.2.3 Recent strategies and developments:
8.2.3.1 Approvals:
8.3 Sanofi S.A.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals:
8.4 Walvax Biotechnology Co., Ltd.
8.4.1 Company Overview
8.5 Bio-Manguinhos (Oswaldo Cruz Foundation)
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.6 Bio-Med Pvt. Ltd.
8.6.1 Company Overview
8.7 Chongqing Zhifei Biological Products Co., Ltd.
8.7.1 Company Overview
8.8 Hualan Biological Engineering, Inc.
8.8.1 Company Overview
8.9 Incepta Pharmaceuticals Ltd.
8.9.1 Company Overview
8.10. Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
Note: Product cover images may vary from those shown
3 of 4
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Sanofi S.A.
  • Walvax Biotechnology Co., Ltd.
  • Bio-Manguinhos (Oswaldo Cruz Foundation)
  • Bio-Med Pvt. Ltd.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • Hualan Biological Engineering, Inc.
  • Incepta Pharmaceuticals Ltd.
  • Serum Institute of India Pvt. Ltd. (Poonawalla Investments & Industries Pvt. Ltd.)
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll